Suresh Kumar Tikoo

USPTO Granted Patents = 16 (Patent Applications = 4)

CIPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 133(Granted Patents)

Company Filing History:

15 out of 213

University of Saskatchewan

where one patent can have more than one assignee

Years Active: 2001-2023

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11839652 - Methods and compositions for inducing protective immunity (2023-12-12),

2. 9333253 - Vaccines for inclusion body hepatitis (2016-05-10),

3. 8524249 - Vaccines for inclusion body hepatitis (2013-09-03),

4. 7687615 - PAV regions for encapsidation and E1 transcriptional control (2010-03-30),

5. RE40930 - Porcine adenovirus type 3 genome (2009-10-05),

6. 7569217 - Porcine adenovirus E1 and E4 regions (2009-08-04),

7. 7560278 - Methods to culture circovirus (2009-07-14),

8. 7335353 - Porcine cells comprising an adenovirus E3 gene region (2008-02-26),

9. 7264818 - BAV packaging regions and E1 transcriptional control regions (2007-09-04),

10. 7172899 - Methods to culture circovirus (2007-02-06),

11. 6849446 - Modified bovine adenovirus having altered tropism (2005-02-01),

12. 6794163 - Methods to culture circovirus (2004-09-21),

13. 6492343 - Porcine adenovirus type 3 genome (2002-12-10),

14. 6458586 - Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors (2002-10-01),

15. 6379944 - Mammalian cell lines expressing bovine adenovirus functions (2002-04-30),

Title: The Innovative Journey of Suresh Kumar Tikoo

Introduction

Suresh Kumar Tikoo, an accomplished inventor based in Saskatoon, Canada, holds an impressive portfolio of 16 patents. His work primarily focuses on advancing immunological methods and compositions that aim to enhance animal health and immunity. His innovations reflect a deep commitment to the fields of veterinary medicine and biotechnology.

Latest Patents

Among his most recent patents, Suresh has developed methodologies and compositions aimed at inducing protective immunity. One such application involves a unique combination of CpG oligodeoxynucleotides complexed to nanoparticles featuring a gemini surfactant, which can be intrapulmonary delivered to enhance immunity in feed animals. Another notable invention is related to vaccines for inclusion body hepatitis. This composition comprises an isolated fowl adenovirus (FAdV) from various serotype strains and showcases a method for inducing protective immunity in both the subject and its progeny.

Career Highlights

Suresh Kumar Tikoo has demonstrated significant contributions to the academic and research community. He has been associated with prominent institutions like the University of Saskatchewan and the University of Guelph, where he has furthered research initiatives focused on immunological advancements. His commitment to furthering veterinary science through innovative research has been noteworthy.

Collaborations

Throughout his career, Suresh has collaborated with esteemed colleagues, including Lorne A. Babiuk and Police Seshidhar Reddy. These partnerships have enriched his research endeavors and fostered a collaborative approach to innovation in veterinary medicine.

Conclusion

Suresh Kumar Tikoo's contributions to the field of immunological research are commendable, showcasing a dedication to improving animal health through innovation. His extensive patent portfolio and collaborations with leading researchers underline his status as a significant figure in the realm of veterinary instrumentation and biotechnology.

This text is generated by artificial intelligence and may not be accurate.